Skip to content

Performance of an Investigational Blood Glucose Monitoring System in a Clinical Trial

Clinical Trial Protocol for Contour Link System With Contour Sensor

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01328717
Enrollment
78
Registered
2011-04-05
Start date
2010-12-31
Completion date
2010-12-31
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

Subjects with diabetes and study staff used an investigational blood glucose monitoring system.

Interventions

DEVICEContour Link Investigational Blood Glucose Monitoring System

Subjects with diabetes and study staff each performed Blood Glucose tests from the subject's capillary blood obtained from fingerstick using the Contour Link investigational meter.

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Males and females, 18 years of age and above * Diagnosed as having type 1 or type 2 diabetes * Currently self-testing blood glucose at home for at least three months * Able to speak, read, and understand English * Willing to complete all study procedures

Exclusion criteria

* Gestational Diabetes * Hemophilia or any other bleeding disorder * Employee of competitive medical device company

Design outcomes

Primary

MeasureTime frameDescription
Percent of Fingerstick Blood Glucose (BG) Results Within +/-20%(>=75 mg/dL) and Within +/- 15mg/dL (<75 mg/dL) of Laboratory Glucose Method1 hourSubjects with diabetes and study staff tested subject fingerstick blood using an investigational blood glucose meter (BGM). BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 20% (for reference BG results \>=75mg/dL) and within +/- 15mg/dL(for reference BG results \<75mg/dL) of the reference method results.

Secondary

MeasureTime frameDescription
Number of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)1 hourSubjects read User Guide(UG)to learn to use the system and performed meter tasks. Study staff observed, then rated subjects' success (1 to 4) at performing tasks. Scale: 1.Performed tasks correctly without assistance. 2.Performed tasks correctly, but was directed to a specific part of the UG by the study staff as in a Customer Service call. 3.Performed tasks correctly, but required additional review/assistance similar to review of a specific function during a Customer Service call. 4.Subject incorrectly performed part of the testing regimen and was unaware of the error.

Countries

United States

Participant flow

Participants by arm

ArmCount
Intended Users of the System
Subjects with diabetes and study staff used an investigational blood glucose monitoring system. As a result of one subject's low blood sugar (and thus rapidly changing glucose values) during the study, 77 subjects completed the study.
77
Total77

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyAdverse Event1

Baseline characteristics

CharacteristicIntended Users of the System
Age, Customized55 years
Region of Enrollment
United States
77 participants
Sex: Female, Male
Female
41 Participants
Sex: Female, Male
Male
36 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
2 / 78
serious
Total, serious adverse events
0 / 78

Outcome results

Primary

Percent of Fingerstick Blood Glucose (BG) Results Within +/-20%(>=75 mg/dL) and Within +/- 15mg/dL (<75 mg/dL) of Laboratory Glucose Method

Subjects with diabetes and study staff tested subject fingerstick blood using an investigational blood glucose meter (BGM). BGM results were compared to a reference lab glucose method - Yellow Springs Instrument (YSI) Analyzer. BG results were used to calculate the number of BG results within +/- 20% (for reference BG results \>=75mg/dL) and within +/- 15mg/dL(for reference BG results \<75mg/dL) of the reference method results.

Time frame: 1 hour

Population: As a result of one subject's low blood sugar (and thus rapidly changing glucose values) during the study, one subject did not complete the study. The remaining 77 subjects tested 2 test strip lots on the system. 2x77(154) test results were available.

ArmMeasureValue (NUMBER)
Intended Users of the SystemPercent of Fingerstick Blood Glucose (BG) Results Within +/-20%(>=75 mg/dL) and Within +/- 15mg/dL (<75 mg/dL) of Laboratory Glucose Method95.5 Percentage of BG test results
Secondary

Number of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)

Subjects read User Guide(UG)to learn to use the system and performed meter tasks. Study staff observed, then rated subjects' success (1 to 4) at performing tasks. Scale: 1.Performed tasks correctly without assistance. 2.Performed tasks correctly, but was directed to a specific part of the UG by the study staff as in a Customer Service call. 3.Performed tasks correctly, but required additional review/assistance similar to review of a specific function during a Customer Service call. 4.Subject incorrectly performed part of the testing regimen and was unaware of the error.

Time frame: 1 hour

Population: Per protocol

ArmMeasureGroupValue (NUMBER)
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)Turn meter on and off77 Number of Participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)Set meter time and date77 Number of Participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)Perform fingerstick blood test77 Number of Participants
Intended Users of the SystemNumber of Subjects Rated as<=3 Performing Basic Meter Tasks (Labeling Evaluation)Perform control test77 Number of Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026